Collaborations & PartnershipsPress ReleaseScience & Research Children’s Tumor Foundation and DELopen Form Collaboration to Increase Access to Promising Compounds for Rare Genetic Disorder
Collaborations & PartnershipsNF1Press ReleaseScience & Research FDA Accepts Submission for Selumetinib as Treatment for Neurofibromatosis and Grants Priority Review
Press ReleaseScience & ResearchSpecial EventsWays to Give Children’s Tumor Foundation Hosts National Gala in New York City
Collaborations & PartnershipsNF1Press ReleaseScience & Research SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for NF1 Patients
Collaborations & PartnershipsNF2-SWNPress ReleaseScience & Research Children’s Tumor Foundation Provides Funding to NF2 Therapeutics, Inc. to Develop a First-in-Class Gene Therapy for NF2-related schwannomatosis
NF2-SWNPress ReleaseScience & Research Children’s Tumor Foundation Launches NF2 Accelerator Initiative to Combat Rare Genetic Disorder
Collaborations & PartnershipsNF1Press ReleasePublicationsScience & Research Nerve Fibers in Skin Are Involved in Initiating Neurofibromas in Patients with Disfiguring Neurofibromatosis 1
AwarenessNF1NF2-SWNPress ReleaseSWN Countries Around the World to Shine a Light on NF on May 17, World NF Awareness Day
